コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 containing 20% (vol/vol) glycerol and 75 mM sodium phosphate.
2 itted by Enceladus that show the presence of sodium phosphates.
3 les were determined, protein, ash, chloride, sodium, phosphate.
4 ditives in products included lecithin (32%), sodium phosphate (13%), calcium phosphate (11%), modifie
6 tment groups: saline solution, dexamethasone sodium phosphate, a nonparticulate steroid, and the part
8 er gave higher purification performance than sodium phosphate and citrate-phosphate buffers in IMAC s
10 loop of GI, termed GII-L, is stable in 10 mM sodium phosphate and is as effective as GI in chromatoso
12 dominis plane (TAP) block with dexamethasone sodium phosphate and preperitoneal instillation of local
14 s stably folded at low ionic strength (10 mM sodium phosphate) and gives strong protection of chromat
15 ow concentrations of impurities (e.g., 20 mM sodium phosphate), and reduces or eliminates the catastr
18 concentrations of SSC, SSPE, PBS, TRIS, MES, sodium phosphate, and potassium phosphate buffers, and f
19 ouble-stranded forms of the 28-mer in 0.01 M sodium phosphate at 25 degrees C, although long-chain (c
20 ty (P(50) = 28.2 mmHg, n(max) = 2.6 in 0.1 M sodium phosphate at pH 7.4) compared to those of Hb A (P
21 y after 120days of storage at 4 degrees C in sodium phosphate buffer (0.1M, pH 7.5), whereas the free
22 U of chondroitinase ABC in 50 microl of 1 mM sodium phosphate buffer (pH 7.0) at 37 degrees C for 6 h
23 heir corresponding DNA/DNA duplexes in 10 mM sodium phosphate buffer (pH 7.0) were determined from di
24 were incubated individually for 2 h in 10 mM sodium phosphate buffer (pH 7.2) containing 0.14 M NaCl,
27 ended mixture consisting in acetonitrile and sodium phosphate buffer 10mmolL(-1) pH = 3.50 (30:70v/v)
28 dine side chains of the mutant rHbs in 0.1 M sodium phosphate buffer at pH 7.0 than for those of Hb A
29 ate that was first dissolved in a 0.1-mmol/L sodium phosphate buffer at pH 7.6 and administered to th
30 ular weight of the proteins extracted with a sodium phosphate buffer containing 2.0% sodium dodecyl s
31 thyl phenylacetyl glucuronide (MPG) in 0.1 M sodium phosphate buffer in D2O at pD 7.4 over 18 h to mo
32 pH pulse produced by freeze-thawing in mixed sodium phosphate buffer induces the oligomerization of D
33 stabilizing agent (i.e., methylene blue and sodium phosphate buffer mixture), the in vitro stability
34 mV shift from CNTs to 7.4 atom % N-CNTs in a sodium phosphate buffer solution (pH 7.0) with 2.0 mM NA
35 n of single-strand DNA, 5'-ATGCTGATGC-3', in sodium phosphate buffer solution at 10 degrees C tempera
36 sition of peroxynitrite (OONO(-)) in aqueous sodium phosphate buffer solution at neutral pH was inves
37 ents of glucose-isomerase concentration in a sodium phosphate buffer that is actively varied over the
38 um dodecyl sulfate from proteins in water or sodium phosphate buffer was achieved by column chromatog
40 (1.0 mM to 0.10 muM bilirubin, measured in a sodium phosphate buffer with pH 8.6) covers the clinical
41 oward neutral to slightly acidic pH in 10 mM sodium phosphate buffer, mitigating the concern of disas
42 ns of our assay (0.05 M sodium citrate/0.1 M sodium phosphate buffer, pH 5.25, 0.2 M NaCl, 0.1 mM EDT
43 el adopts a random-coil conformation in 2 mm sodium phosphate buffer, pH 5.5, and becomes an alpha he
45 mbda em = 393 nm) in Tris buffer, pH 9.0, or sodium phosphate buffer, pH 7.2, but under the same cond
46 , 0.01-0.06 mM] but not in 0.14 M NaCl/10 mM sodium phosphate buffer, pH 7.2/0.5 mM CaCl2/0.15 mM MgC
47 of 1.0 mug muL(-1) stock solutions in 100 mM sodium phosphate buffers (pH 1-12) at room temperature.
48 genes encoding the kidney-specific type IIa sodium phosphate co-transporter (SLC34A1), the calcium-s
50 that scaffolds membrane proteins, including sodium-phosphate co-transport protein 2A (NPT2A) at the
52 reduction in the protein levels of the renal sodium-phosphate co-transporter NaPi-IIa in the proximal
53 layed higher renal protein expression of the sodium-phosphate co-transporter NaPi-IIa, lower renal Kl
54 deficiency in the pulmonary epithelial Npt2b sodium-phosphate co-transporter that results in accumula
55 intra-erythrocyte delivery of dexamethasone sodium phosphate compared with placebo in children with
56 was dependent on alkyl side chain length and sodium phosphate concentration, but the same effects wer
59 yroid hormone inhibits proximal renal tubule sodium-phosphate cotransport through a signaling complex
60 ogic regulator of proximal renal tubule cell sodium-phosphate cotransport, stimulates several signal
63 s a carboxy-terminal PDZ ligand required for sodium phosphate cotransporter 2a (NPT2A) and sodium hyd
64 panning protein that functions as a type III sodium phosphate cotransporter and as the receptor for a
65 hybridize to the message for the rat kidney sodium phosphate cotransporter NaPi-2 close to the trans
66 evels and decreased kidney membrane type IIa sodium phosphate cotransporter protein, as was the case
67 ranscripts for hBNP-1, a type 1b human brain sodium phosphate cotransporter, and cystic fibrosis tran
69 on of phosphate uptake and PTH regulation of sodium-phosphate cotransporter (NaPi-4) expression were
70 ein (AKAP) by demonstrating that the type II sodium-phosphate cotransporter (NaPi-4) physically assoc
71 expression of the major apical transporters sodium-phosphate cotransporter 2A (NaPi-IIa) and sodium-
72 ising candidate gene, SLC34A1 encoding renal sodium-phosphate cotransporter 2A (NaPi-IIa), revealed a
74 sive genes, we inadvertently discovered that sodium-phosphate cotransporter 2B (NaPi-2b) mRNA concent
75 med by co-transfecting HEK293 cells with the sodium-phosphate cotransporter and wild type AKAP, a mut
79 FGF23 levels and abundant expression of the sodium-phosphate cotransporter Npt2a at the brush border
80 n of recombinant cKL downregulated the renal sodium-phosphate cotransporter Npt2a in alphaKL-null mic
84 o bound other cellular targets including the sodium-phosphate cotransporter type IIa encoded by the N
86 also measured the expression of aquaporin-2, sodium/phosphate cotransporter (NaPi)-2, paracellin-1, a
88 The PIT1/SLC20A1 protein, a well-described sodium/phosphate cotransporter and retrovirus receptor,
89 mice have increased renal expression of the sodium/phosphate cotransporter NaP(i)2a and of 1- alpha-
90 se in the transport activity of the type IIa sodium/phosphate cotransporter protein (NaPi) despite an
92 ses suggest that increased renal activity of sodium-phosphate cotransporters (NaPi2a) leads to severe
93 s in the SLC34A1 and SLC34A3 genes, encoding sodium-phosphate cotransporters 2a (NPT2a) and 2c (NPT2c
94 xcretion by reducing expression of the renal sodium-phosphate cotransporters NaPi-IIa and NaPi-IIc in
97 ace amounts of solutes with hydroxyl groups (sodium phosphate dibasic, potassium phosphate monobasic,
99 PLGA) nanoparticles containing dexamethasone sodium phosphate (DSP) exhibited a size of 200 nm, 8 wt.
100 soluble form of dexamethasone, dexamethasone sodium phosphate (DSP), that has been demonstrated to ac
102 imizations revealed that sodium carbonate or sodium phosphate followed by DHB sublimation increases t
103 d 118 consecutive patients given single-dose sodium phosphate for bowel catharsis and 115 consecutive
104 8.6% (627 of 708) of colonic segments in the sodium phosphate group and in 88.1% (608 of 690) in the
105 ntly different between magnesium citrate and sodium phosphate groups (790 HU +/- 216 vs 978 HU +/- 16
106 weak chromatosome protection, but in 250 mM sodium phosphate has a structure very similar to that of
110 dministered pegylated liposomal prednisolone sodium phosphate (Nanocort) was compared to equipotent i
111 to receive either 2 mL (8 mg) dexamethasone sodium phosphate or 2 mL of IV solution (placebo) before
112 sphorylated or acetylated by Ac~P and either sodium phosphate or potassium phosphate, which are not p
113 , 2.60; 95% confidence interval, 1.46-4.63), sodium phosphate (OR, 9.34; 95% confidence interval, 2.1
114 ly 14-22 mg) intra-erythrocyte dexamethasone sodium phosphate, or placebo, using an independent inter
116 t formation, autolyzed more rapidly in 10 mM sodium phosphate (pH 6.8), and, in contrast to strains t
118 Likewise, the formation of alanine in 500 mM sodium phosphate (pH 7.0) from 5 mM glyceraldehyde and 1
119 yde and ammonium ion in aqueous solutions of sodium phosphate (pH 7.0) or imidazole-imidazolium chlor
121 dodecyl sulfate (SDS) and 1-butanol in 10 mM sodium-phosphate (pH 7.2) at a flow rate of 5 mL/min.
122 sensitivity and speed of analysis were 50 mM sodium phosphate, pH 2.3, and 100 mM ammonium formate, p
124 ibrils after incubation (37 degrees C, 10 mM sodium phosphate, pH 7.60), but in contrast to beta-shee
125 embranes prepared by hypotonic lysis in 5 mM sodium phosphate, pH 8.0 (5P8), conditions in which the
126 oscopy, including polyethylene glycol (PEG), sodium phosphate, picosulfate, or oral sulfate solutions
131 multicenter trial compared 1.0% prednisolone sodium phosphate to placebo in the treatment of bacteria
132 genes with structural similarity to a type 1 sodium phosphate transporter, 12 novel histone genes, an
133 nic variants in SLC34A1 and SLC34A3 encoding sodium-phosphate transporter 2a and 2c are rare causes o
134 delivery (PBS pH 7.2 and 0.9% saline), and a sodium phosphate vehicle previously shown to enhance the
135 fference seen in the sigmoid colon (2.17 for sodium phosphate vs 2.44 for magnesium citrate; P< 0.01)
136 Intravenous intra-erythrocyte dexamethasone sodium phosphate was administered once a month for 6 mon
138 intra-erythrocyte delivery of dexamethasone sodium phosphate will continue in participants aged 6-9
140 II-L is very similar to GII folded in 250 mM sodium phosphate, with the exception of the substituted
141 1 M triflic acid) and 1150 mV at pH 6 (10 mM sodium phosphate) yielded a red colored solution with a